08-Jul-2019 | Zion Market Research
Zion Market Research has published a new report titled “Critical Limb Ischemia Treatment Market By Treatment (Devices and Medications): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, the demand for global critical limb ischemia treatment market was USD 3,129 million in 2018 and is expected to generate USD 5,390 million by 2025, at a CAGR of 8.1% between 2019 and 2025.
Critical limb ischemia is a chronic disease of peripheral arteries, in which chronic inflammation allied with atherosclerosis causes abridged flow of blood and oxygen to the legs, hands, and feet. This, in turn, leads to chronic pain and soreness. The key factors responsible for critical limb ischemia disease include aging, as geriatric people are more susceptible to the development of these conditions, diabetes, obesity, extremely high cholesterol levels, sedentary lifestyle, smoking, and increased blood pressure. Untreated critical limb ischemia can even lead to amputation of the specific limb. An average of 25% of patients with critical limb ischemia loses a limb. The growing prevalence of critical limb ischemia is expected to drive the demand for its treatment, which, in turn, is predicted to propel the growth of the critical limb ischemia treatment market globally.
Browse the full “Critical Limb Ischemia Treatment Market By Treatment (Devices and Medications): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025” Report at https://www.zionmarketresearch.com/report/critical-limb-ischemia-treatment-market
The critical limb ischemia treatment market is fragmented on the basis of treatment and region. By treatment, the market is segmented into two major categories—devices and medications. On the basis of devices, the global critical limb ischemia treatment market includes peripheral dilatation systems and embolic protection devices. The peripheral dilatation systems are further classified into vascular stents, and balloon dilators. In terms of revenue share, the devices segment accounted for the major share in the global market in 2018 and is expected to register the highest CAGR in the over the forecast timeframe. This can be due to the growing demand for technically advanced treatments, such as balloons and stents, to treat critical limb ischemia. The peripheral dilatation systems dominated the market 2018, as these devices provide efficient dilation and shield the artery walls.
The medications segment of the critical limb ischemia treatment market includes antihypertensive agents, antiplatelet drugs, antithrombotic agents, lipid-lowering agents, and others. In terms of growth rate, the critical limb ischemia devices segment is expected to register the highest CAGR in the global market over the forecasted time span. About 40% of patients are not suitable for surgical interventions, such as revascularization, and hence, the development of medication for such diseases is growing rapidly. For instance, PLX-PAD is a phase III molecule, which is among the most promising new reformative and cell rehabilitation.
North American and European regions dominated the global critical limb ischemia treatment market with substantial market shares in the year 2018. This can be attributed to the high obesity rate, growing ischemia diseases due to unhealthy lifestyles across North America. The Asia Pacific region is expected to register the highest growth in the global critical limb ischemia treatment market in the years to come, owing to the increasing awareness among the regional population about the critical limb ischemia.
Some major players of the global critical limb ischemia treatment market are Boston Scientific Corporation, Medtronic, Cesca Therapeutics, Pluristem Therapeutics, Abbott Laboratories, Rexgenero, Micro Medical Solutions, LimFlow, and Cardiovascular Systems.
This report segments the global critical limb ischemia treatment market into:
Global Critical Limb Ischemia Treatment Market: Drug Type Analysis
Global Critical Limb Ischemia Treatment Market: Regional Analysis
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651